Welcome to our blog, featuring stories from Albertans like you.

Our blog features stories from some of the 53 Albertans and their familes who hear the words “you have cancer.” every day.

Share Your Story

Bernice Heisler shares her journey with breast cancer

Tuesday, May 3, 2022

On the day of her late brother’s birthday, Bernice Heisler was diagnosed with cancer. “That phone call hit me like a ton of bricks,” she recalls. Bernice Heisler’s cancer journey began in 2019 when she found a lump in her left breast while on vacation in BC. When she was tested, it was found to … Read More


Read More

Facing Cancer as a Young Adult – Tyra from Edmonton shares her story

Tuesday, April 12, 2022

Tyra Langille was only 25 years old when she was diagnosed with oral squamous cell carcinoma. The Edmontonian shares her cancer journey and why it’s important to her to raise awareness for oral cancer and advocate for other young cancer patients.  My journey is not over, the healing process is slow and I take every … Read More


Read More

Why Katie Cowie gives back

Thursday, March 17, 2022

Katie Cowie’s cancer journey began when she found a lump in her right breast in late March of 2021. She was officially diagnosed a month later with Invasive Ductal Carcinoma, HER2+.  Shortly after, Katie received a bilateral mastectomy at the Peter Lougheed Hospital, followed by chemotherapy and maintenance therapy at the Tom Baker Cancer Centre. … Read More


Read More

Why the Doirons chose to make a gift in their will

Thursday, March 10, 2022

Jill and Charlie Doiron are longtime supporters of the Alberta Cancer Foundation. Driven by the impact clinical trials have had on Jill’s own cancer journey, Jill and Charlie are committed to supporting local advancements and Investigator-Initiated Clinical Trials for the future of cancer care. This commitment is promised beyond their lifetime. Here, Jill Doiron shares … Read More


Read More
We Cross Cancer

In honour of International Clinical Trials Day, please consider making a gift that will help double our capacity for life-saving clinical trials at the Cross Cancer Institute.